▶ 調査レポート

アバナフィルAPIのグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Avanafil API Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。アバナフィルAPIのグローバル市場インサイト・予測(~2028年) / Global Avanafil API Market Insights, Forecast to 2028 / MRC2Q12-01035資料のイメージです。• レポートコード:MRC2Q12-01035
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、89ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
コロナ禍により、アバナフィルAPIの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にアバナフィルAPIのグローバル市場のxxx%を占める「≥99.0%」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「錠剤」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
アバナフィルAPIの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのアバナフィルAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

アバナフィルAPIのグローバル主要プレイヤーには、Honour Lab Limited、Polpharma SA、Century Pharmaceuticals Ltd、Tosun United Pharma and Group、DEAFARMA、Hangzhou Longshine Bio-Tech CO., Ltd、Hangzhou think chemical Co.Ltd.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

アバナフィルAPI市場は、種類と用途によって区分されます。世界のアバナフィルAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
≥99.0%、≥98.0%

【用途別セグメント】
錠剤、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- アバナフィルAPI製品概要
- 種類別市場(≥99.0%、≥98.0%)
- 用途別市場(錠剤、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のアバナフィルAPI販売量予測2017-2028
- 世界のアバナフィルAPI売上予測2017-2028
- アバナフィルAPIの地域別販売量
- アバナフィルAPIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別アバナフィルAPI販売量
- 主要メーカー別アバナフィルAPI売上
- 主要メーカー別アバナフィルAPI価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(≥99.0%、≥98.0%)
- アバナフィルAPIの種類別販売量
- アバナフィルAPIの種類別売上
- アバナフィルAPIの種類別価格
・用途別市場規模(錠剤、その他)
- アバナフィルAPIの用途別販売量
- アバナフィルAPIの用途別売上
- アバナフィルAPIの用途別価格
・北米市場
- 北米のアバナフィルAPI市場規模(種類別、用途別)
- 主要国別のアバナフィルAPI市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのアバナフィルAPI市場規模(種類別、用途別)
- 主要国別のアバナフィルAPI市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のアバナフィルAPI市場規模(種類別、用途別)
- 主要国別のアバナフィルAPI市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のアバナフィルAPI市場規模(種類別、用途別)
- 主要国別のアバナフィルAPI市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのアバナフィルAPI市場規模(種類別、用途別)
- 主要国別のアバナフィルAPI市場規模(トルコ、サウジアラビア)
・企業情報
Honour Lab Limited、Polpharma SA、Century Pharmaceuticals Ltd、Tosun United Pharma and Group、DEAFARMA、Hangzhou Longshine Bio-Tech CO., Ltd、Hangzhou think chemical Co.Ltd.
・産業チェーン及び販売チャネル分析
- アバナフィルAPIの産業チェーン分析
- アバナフィルAPIの原材料
- アバナフィルAPIの生産プロセス
- アバナフィルAPIの販売及びマーケティング
- アバナフィルAPIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- アバナフィルAPIの産業動向
- アバナフィルAPIのマーケットドライバー
- アバナフィルAPIの課題
- アバナフィルAPIの阻害要因
・主な調査結果

Avanafil acts by inhibiting a specific phosphodiesterase type 5 enzyme found in various body tissues, primarily in the corpus cavernosum penis. Other similar drugs are sildenafil, tadalafil and vardenafil. The advantage of avanafil is that it has very fast onset of action compared with other PDE5 inhibitors. It is absorbed quickly, reaching a maximum serum concentration in about thirty to forty-five minutes.[7] About two-thirds of the participants were able to engage in sexual activity within fifteen minutes.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Avanafil API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Avanafil API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Avanafil API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Avanafil API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Avanafil API include Honour Lab Limited, Polpharma SA, Century Pharmaceuticals Ltd, Tosun United Pharma and Group, DEAFARMA, Hangzhou Longshine Bio-Tech CO., Ltd and Hangzhou think chemical Co.Ltd., etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Avanafil API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Avanafil API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Avanafil API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Avanafil API market. Further, it explains the major drivers and regional dynamics of the global Avanafil API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Honour Lab Limited
Polpharma SA
Century Pharmaceuticals Ltd
Tosun United Pharma and Group
DEAFARMA
Hangzhou Longshine Bio-Tech CO., Ltd
Hangzhou think chemical Co.Ltd.
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Avanafil API Segment by Type
≥99.0%
≥98.0%
Avanafil API Segment by Application
Tablets
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Avanafil API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Avanafil API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Avanafil API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Avanafil API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Avanafil API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Avanafil API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Avanafil API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Avanafil API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Honour Lab Limited, Polpharma SA, Century Pharmaceuticals Ltd, Tosun United Pharma and Group, DEAFARMA, Hangzhou Longshine Bio-Tech CO., Ltd and Hangzhou think chemical Co.Ltd., etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Avanafil API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Avanafil API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Avanafil API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Avanafil API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

レポート目次

1 Study Coverage
1.1 Avanafil API Product Introduction
1.2 Market by Type
1.2.1 Global Avanafil API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 ≥99.0%
1.2.3 ≥98.0%
1.3 Market by Application
1.3.1 Global Avanafil API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Tablets
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Avanafil API Production
2.1 Global Avanafil API Production Capacity (2017-2028)
2.2 Global Avanafil API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Avanafil API Production by Region
2.3.1 Global Avanafil API Historic Production by Region (2017-2022)
2.3.2 Global Avanafil API Forecasted Production by Region (2023-2028)
2.4 Europe
2.5 China
2.6 India
3 Global Avanafil API Sales in Volume & Value Estimates and Forecasts
3.1 Global Avanafil API Sales Estimates and Forecasts 2017-2028
3.2 Global Avanafil API Revenue Estimates and Forecasts 2017-2028
3.3 Global Avanafil API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Avanafil API Sales by Region
3.4.1 Global Avanafil API Sales by Region (2017-2022)
3.4.2 Global Sales Avanafil API by Region (2023-2028)
3.5 Global Avanafil API Revenue by Region
3.5.1 Global Avanafil API Revenue by Region (2017-2022)
3.5.2 Global Avanafil API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Avanafil API Production Capacity by Manufacturers
4.2 Global Avanafil API Sales by Manufacturers
4.2.1 Global Avanafil API Sales by Manufacturers (2017-2022)
4.2.2 Global Avanafil API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Avanafil API in 2021
4.3 Global Avanafil API Revenue by Manufacturers
4.3.1 Global Avanafil API Revenue by Manufacturers (2017-2022)
4.3.2 Global Avanafil API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Avanafil API Revenue in 2021
4.4 Global Avanafil API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Avanafil API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Avanafil API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Avanafil API Sales by Type
5.1.1 Global Avanafil API Historical Sales by Type (2017-2022)
5.1.2 Global Avanafil API Forecasted Sales by Type (2023-2028)
5.1.3 Global Avanafil API Sales Market Share by Type (2017-2028)
5.2 Global Avanafil API Revenue by Type
5.2.1 Global Avanafil API Historical Revenue by Type (2017-2022)
5.2.2 Global Avanafil API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Avanafil API Revenue Market Share by Type (2017-2028)
5.3 Global Avanafil API Price by Type
5.3.1 Global Avanafil API Price by Type (2017-2022)
5.3.2 Global Avanafil API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Avanafil API Sales by Application
6.1.1 Global Avanafil API Historical Sales by Application (2017-2022)
6.1.2 Global Avanafil API Forecasted Sales by Application (2023-2028)
6.1.3 Global Avanafil API Sales Market Share by Application (2017-2028)
6.2 Global Avanafil API Revenue by Application
6.2.1 Global Avanafil API Historical Revenue by Application (2017-2022)
6.2.2 Global Avanafil API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Avanafil API Revenue Market Share by Application (2017-2028)
6.3 Global Avanafil API Price by Application
6.3.1 Global Avanafil API Price by Application (2017-2022)
6.3.2 Global Avanafil API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Avanafil API Market Size by Type
7.1.1 North America Avanafil API Sales by Type (2017-2028)
7.1.2 North America Avanafil API Revenue by Type (2017-2028)
7.2 North America Avanafil API Market Size by Application
7.2.1 North America Avanafil API Sales by Application (2017-2028)
7.2.2 North America Avanafil API Revenue by Application (2017-2028)
7.3 North America Avanafil API Sales by Country
7.3.1 North America Avanafil API Sales by Country (2017-2028)
7.3.2 North America Avanafil API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Avanafil API Market Size by Type
8.1.1 Europe Avanafil API Sales by Type (2017-2028)
8.1.2 Europe Avanafil API Revenue by Type (2017-2028)
8.2 Europe Avanafil API Market Size by Application
8.2.1 Europe Avanafil API Sales by Application (2017-2028)
8.2.2 Europe Avanafil API Revenue by Application (2017-2028)
8.3 Europe Avanafil API Sales by Country
8.3.1 Europe Avanafil API Sales by Country (2017-2028)
8.3.2 Europe Avanafil API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Avanafil API Market Size by Type
9.1.1 Asia Pacific Avanafil API Sales by Type (2017-2028)
9.1.2 Asia Pacific Avanafil API Revenue by Type (2017-2028)
9.2 Asia Pacific Avanafil API Market Size by Application
9.2.1 Asia Pacific Avanafil API Sales by Application (2017-2028)
9.2.2 Asia Pacific Avanafil API Revenue by Application (2017-2028)
9.3 Asia Pacific Avanafil API Sales by Region
9.3.1 Asia Pacific Avanafil API Sales by Region (2017-2028)
9.3.2 Asia Pacific Avanafil API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Avanafil API Market Size by Type
10.1.1 Latin America Avanafil API Sales by Type (2017-2028)
10.1.2 Latin America Avanafil API Revenue by Type (2017-2028)
10.2 Latin America Avanafil API Market Size by Application
10.2.1 Latin America Avanafil API Sales by Application (2017-2028)
10.2.2 Latin America Avanafil API Revenue by Application (2017-2028)
10.3 Latin America Avanafil API Sales by Country
10.3.1 Latin America Avanafil API Sales by Country (2017-2028)
10.3.2 Latin America Avanafil API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Avanafil API Market Size by Type
11.1.1 Middle East and Africa Avanafil API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Avanafil API Revenue by Type (2017-2028)
11.2 Middle East and Africa Avanafil API Market Size by Application
11.2.1 Middle East and Africa Avanafil API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Avanafil API Revenue by Application (2017-2028)
11.3 Middle East and Africa Avanafil API Sales by Country
11.3.1 Middle East and Africa Avanafil API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Avanafil API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Honour Lab Limited
12.1.1 Honour Lab Limited Corporation Information
12.1.2 Honour Lab Limited Overview
12.1.3 Honour Lab Limited Avanafil API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Honour Lab Limited Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Honour Lab Limited Recent Developments
12.2 Polpharma SA
12.2.1 Polpharma SA Corporation Information
12.2.2 Polpharma SA Overview
12.2.3 Polpharma SA Avanafil API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Polpharma SA Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Polpharma SA Recent Developments
12.3 Century Pharmaceuticals Ltd
12.3.1 Century Pharmaceuticals Ltd Corporation Information
12.3.2 Century Pharmaceuticals Ltd Overview
12.3.3 Century Pharmaceuticals Ltd Avanafil API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Century Pharmaceuticals Ltd Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Century Pharmaceuticals Ltd Recent Developments
12.4 Tosun United Pharma and Group
12.4.1 Tosun United Pharma and Group Corporation Information
12.4.2 Tosun United Pharma and Group Overview
12.4.3 Tosun United Pharma and Group Avanafil API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Tosun United Pharma and Group Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Tosun United Pharma and Group Recent Developments
12.5 DEAFARMA
12.5.1 DEAFARMA Corporation Information
12.5.2 DEAFARMA Overview
12.5.3 DEAFARMA Avanafil API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 DEAFARMA Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 DEAFARMA Recent Developments
12.6 Hangzhou Longshine Bio-Tech CO., Ltd
12.6.1 Hangzhou Longshine Bio-Tech CO., Ltd Corporation Information
12.6.2 Hangzhou Longshine Bio-Tech CO., Ltd Overview
12.6.3 Hangzhou Longshine Bio-Tech CO., Ltd Avanafil API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Hangzhou Longshine Bio-Tech CO., Ltd Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Hangzhou Longshine Bio-Tech CO., Ltd Recent Developments
12.7 Hangzhou think chemical Co.Ltd.
12.7.1 Hangzhou think chemical Co.Ltd. Corporation Information
12.7.2 Hangzhou think chemical Co.Ltd. Overview
12.7.3 Hangzhou think chemical Co.Ltd. Avanafil API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Hangzhou think chemical Co.Ltd. Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Hangzhou think chemical Co.Ltd. Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Avanafil API Industry Chain Analysis
13.2 Avanafil API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Avanafil API Production Mode & Process
13.4 Avanafil API Sales and Marketing
13.4.1 Avanafil API Sales Channels
13.4.2 Avanafil API Distributors
13.5 Avanafil API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Avanafil API Industry Trends
14.2 Avanafil API Market Drivers
14.3 Avanafil API Market Challenges
14.4 Avanafil API Market Restraints
15 Key Finding in The Global Avanafil API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Avanafil API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of ≥99.0%
Table 3. Major Manufacturers of ≥98.0%
Table 4. Global Avanafil API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Avanafil API Production by Region: 2017 VS 2021 VS 2028 (Kg)
Table 6. Global Avanafil API Production by Region (2017-2022) & (Kg)
Table 7. Global Avanafil API Production Market Share by Region (2017-2022)
Table 8. Global Avanafil API Production by Region (2023-2028) & (Kg)
Table 9. Global Avanafil API Production Market Share by Region (2023-2028)
Table 10. Global Avanafil API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Avanafil API Sales by Region (2017-2022) & (Kg)
Table 12. Global Avanafil API Sales Market Share by Region (2017-2022)
Table 13. Global Avanafil API Sales by Region (2023-2028) & (Kg)
Table 14. Global Avanafil API Sales Market Share by Region (2023-2028)
Table 15. Global Avanafil API Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Avanafil API Revenue Market Share by Region (2017-2022)
Table 17. Global Avanafil API Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Avanafil API Revenue Market Share by Region (2023-2028)
Table 19. Global Avanafil API Production Capacity by Manufacturers (2017-2022) & (Kg)
Table 20. Global Avanafil API Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Avanafil API Sales by Manufacturers (2017-2022) & (Kg)
Table 22. Global Avanafil API Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Avanafil API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Avanafil API Revenue Share by Manufacturers (2017-2022)
Table 25. Avanafil API Price by Manufacturers 2017-2022 (US$/Kg)
Table 26. Global Avanafil API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Avanafil API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avanafil API as of 2021)
Table 28. Avanafil API Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Avanafil API Product Offered
Table 30. Date of Manufacturers Enter into Avanafil API Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Avanafil API Sales by Type (2017-2022) & (Kg)
Table 33. Global Avanafil API Sales by Type (2023-2028) & (Kg)
Table 34. Global Avanafil API Sales Share by Type (2017-2022)
Table 35. Global Avanafil API Sales Share by Type (2023-2028)
Table 36. Global Avanafil API Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Avanafil API Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Avanafil API Revenue Share by Type (2017-2022)
Table 39. Global Avanafil API Revenue Share by Type (2023-2028)
Table 40. Avanafil API Price by Type (2017-2022) & (US$/Kg)
Table 41. Global Avanafil API Price Forecast by Type (2023-2028) & (US$/Kg)
Table 42. Global Avanafil API Sales by Application (2017-2022) & (Kg)
Table 43. Global Avanafil API Sales by Application (2023-2028) & (Kg)
Table 44. Global Avanafil API Sales Share by Application (2017-2022)
Table 45. Global Avanafil API Sales Share by Application (2023-2028)
Table 46. Global Avanafil API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Avanafil API Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Avanafil API Revenue Share by Application (2017-2022)
Table 49. Global Avanafil API Revenue Share by Application (2023-2028)
Table 50. Avanafil API Price by Application (2017-2022) & (US$/Kg)
Table 51. Global Avanafil API Price Forecast by Application (2023-2028) & (US$/Kg)
Table 52. North America Avanafil API Sales by Type (2017-2022) & (Kg)
Table 53. North America Avanafil API Sales by Type (2023-2028) & (Kg)
Table 54. North America Avanafil API Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Avanafil API Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Avanafil API Sales by Application (2017-2022) & (Kg)
Table 57. North America Avanafil API Sales by Application (2023-2028) & (Kg)
Table 58. North America Avanafil API Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Avanafil API Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Avanafil API Sales by Country (2017-2022) & (Kg)
Table 61. North America Avanafil API Sales by Country (2023-2028) & (Kg)
Table 62. North America Avanafil API Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Avanafil API Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Avanafil API Sales by Type (2017-2022) & (Kg)
Table 65. Europe Avanafil API Sales by Type (2023-2028) & (Kg)
Table 66. Europe Avanafil API Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Avanafil API Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Avanafil API Sales by Application (2017-2022) & (Kg)
Table 69. Europe Avanafil API Sales by Application (2023-2028) & (Kg)
Table 70. Europe Avanafil API Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Avanafil API Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Avanafil API Sales by Country (2017-2022) & (Kg)
Table 73. Europe Avanafil API Sales by Country (2023-2028) & (Kg)
Table 74. Europe Avanafil API Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Avanafil API Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Avanafil API Sales by Type (2017-2022) & (Kg)
Table 77. Asia Pacific Avanafil API Sales by Type (2023-2028) & (Kg)
Table 78. Asia Pacific Avanafil API Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Avanafil API Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Avanafil API Sales by Application (2017-2022) & (Kg)
Table 81. Asia Pacific Avanafil API Sales by Application (2023-2028) & (Kg)
Table 82. Asia Pacific Avanafil API Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Avanafil API Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Avanafil API Sales by Region (2017-2022) & (Kg)
Table 85. Asia Pacific Avanafil API Sales by Region (2023-2028) & (Kg)
Table 86. Asia Pacific Avanafil API Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Avanafil API Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Avanafil API Sales by Type (2017-2022) & (Kg)
Table 89. Latin America Avanafil API Sales by Type (2023-2028) & (Kg)
Table 90. Latin America Avanafil API Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Avanafil API Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Avanafil API Sales by Application (2017-2022) & (Kg)
Table 93. Latin America Avanafil API Sales by Application (2023-2028) & (Kg)
Table 94. Latin America Avanafil API Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Avanafil API Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Avanafil API Sales by Country (2017-2022) & (Kg)
Table 97. Latin America Avanafil API Sales by Country (2023-2028) & (Kg)
Table 98. Latin America Avanafil API Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Avanafil API Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Avanafil API Sales by Type (2017-2022) & (Kg)
Table 101. Middle East and Africa Avanafil API Sales by Type (2023-2028) & (Kg)
Table 102. Middle East and Africa Avanafil API Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Avanafil API Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Avanafil API Sales by Application (2017-2022) & (Kg)
Table 105. Middle East and Africa Avanafil API Sales by Application (2023-2028) & (Kg)
Table 106. Middle East and Africa Avanafil API Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Avanafil API Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Avanafil API Sales by Country (2017-2022) & (Kg)
Table 109. Middle East and Africa Avanafil API Sales by Country (2023-2028) & (Kg)
Table 110. Middle East and Africa Avanafil API Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Avanafil API Revenue by Country (2023-2028) & (US$ Million)
Table 112. Honour Lab Limited Corporation Information
Table 113. Honour Lab Limited Description and Major Businesses
Table 114. Honour Lab Limited Avanafil API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 115. Honour Lab Limited Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Honour Lab Limited Recent Development
Table 117. Polpharma SA Corporation Information
Table 118. Polpharma SA Description and Major Businesses
Table 119. Polpharma SA Avanafil API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 120. Polpharma SA Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Polpharma SA Recent Development
Table 122. Century Pharmaceuticals Ltd Corporation Information
Table 123. Century Pharmaceuticals Ltd Description and Major Businesses
Table 124. Century Pharmaceuticals Ltd Avanafil API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 125. Century Pharmaceuticals Ltd Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Century Pharmaceuticals Ltd Recent Development
Table 127. Tosun United Pharma and Group Corporation Information
Table 128. Tosun United Pharma and Group Description and Major Businesses
Table 129. Tosun United Pharma and Group Avanafil API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 130. Tosun United Pharma and Group Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Tosun United Pharma and Group Recent Development
Table 132. DEAFARMA Corporation Information
Table 133. DEAFARMA Description and Major Businesses
Table 134. DEAFARMA Avanafil API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 135. DEAFARMA Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. DEAFARMA Recent Development
Table 137. Hangzhou Longshine Bio-Tech CO., Ltd Corporation Information
Table 138. Hangzhou Longshine Bio-Tech CO., Ltd Description and Major Businesses
Table 139. Hangzhou Longshine Bio-Tech CO., Ltd Avanafil API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 140. Hangzhou Longshine Bio-Tech CO., Ltd Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Hangzhou Longshine Bio-Tech CO., Ltd Recent Development
Table 142. Hangzhou think chemical Co.Ltd. Corporation Information
Table 143. Hangzhou think chemical Co.Ltd. Description and Major Businesses
Table 144. Hangzhou think chemical Co.Ltd. Avanafil API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 145. Hangzhou think chemical Co.Ltd. Avanafil API Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Hangzhou think chemical Co.Ltd. Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Avanafil API Distributors List
Table 150. Avanafil API Customers List
Table 151. Avanafil API Market Trends
Table 152. Avanafil API Market Drivers
Table 153. Avanafil API Market Challenges
Table 154. Avanafil API Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Avanafil API Product Picture
Figure 2. Global Avanafil API Market Share by Type in 2021 & 2028
Figure 3. ≥99.0% Product Picture
Figure 4. ≥98.0% Product Picture
Figure 5. Global Avanafil API Market Share by Application in 2021 & 2028
Figure 6. Tablets
Figure 7. Others
Figure 8. Avanafil API Report Years Considered
Figure 9. Global Avanafil API Capacity, Production and Utilization (2017-2028) & (Kg)
Figure 10. Global Avanafil API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 11. Global Avanafil API Production Market Share by Region (2017-2022)
Figure 12. Global Avanafil API Production Market Share by Region (2023-2028)
Figure 13. Avanafil API Production Growth Rate in Europe (2017-2028) & (Kg)
Figure 14. Avanafil API Production Growth Rate in China (2017-2028) & (Kg)
Figure 15. Avanafil API Production Growth Rate in India (2017-2028) & (Kg)
Figure 16. Global Avanafil API Sales 2017-2028 (Kg)
Figure 17. Global Avanafil API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Avanafil API Revenue 2017-2028 (US$ Million)
Figure 19. Global Avanafil API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Avanafil API Sales Market Share by Region (2017-2022)
Figure 21. Global Avanafil API Sales Market Share by Region (2023-2028)
Figure 22. North America Avanafil API Sales YoY (2017-2028) & (Kg)
Figure 23. North America Avanafil API Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Avanafil API Sales YoY (2017-2028) & (Kg)
Figure 25. Europe Avanafil API Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Avanafil API Sales YoY (2017-2028) & (Kg)
Figure 27. Asia-Pacific Avanafil API Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Avanafil API Sales YoY (2017-2028) & (Kg)
Figure 29. Latin America Avanafil API Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Avanafil API Sales YoY (2017-2028) & (Kg)
Figure 31. Middle East & Africa Avanafil API Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Avanafil API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Avanafil API in the World: Market Share by Avanafil API Revenue in 2021
Figure 34. Avanafil API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Avanafil API Sales Market Share by Type (2017-2028)
Figure 36. Global Avanafil API Revenue Market Share by Type (2017-2028)
Figure 37. Global Avanafil API Sales Market Share by Application (2017-2028)
Figure 38. Global Avanafil API Revenue Market Share by Application (2017-2028)
Figure 39. North America Avanafil API Sales Market Share by Type (2017-2028)
Figure 40. North America Avanafil API Revenue Market Share by Type (2017-2028)
Figure 41. North America Avanafil API Sales Market Share by Application (2017-2028)
Figure 42. North America Avanafil API Revenue Market Share by Application (2017-2028)
Figure 43. North America Avanafil API Sales Share by Country (2017-2028)
Figure 44. North America Avanafil API Revenue Share by Country (2017-2028)
Figure 45. United States Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Avanafil API Sales Market Share by Type (2017-2028)
Figure 48. Europe Avanafil API Revenue Market Share by Type (2017-2028)
Figure 49. Europe Avanafil API Sales Market Share by Application (2017-2028)
Figure 50. Europe Avanafil API Revenue Market Share by Application (2017-2028)
Figure 51. Europe Avanafil API Sales Share by Country (2017-2028)
Figure 52. Europe Avanafil API Revenue Share by Country (2017-2028)
Figure 53. Germany Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 54. France Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Avanafil API Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Avanafil API Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Avanafil API Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Avanafil API Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Avanafil API Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Avanafil API Revenue Share by Region (2017-2028)
Figure 64. China Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 67. India Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 69. China Taiwan Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Avanafil API Sales Market Share by Type (2017-2028)
Figure 74. Latin America Avanafil API Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Avanafil API Sales Market Share by Application (2017-2028)
Figure 76. Latin America Avanafil API Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Avanafil API Sales Share by Country (2017-2028)
Figure 78. Latin America Avanafil API Revenue Share by Country (2017-2028)
Figure 79. Mexico Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 82. Colombia Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Avanafil API Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Avanafil API Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Avanafil API Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Avanafil API Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Avanafil API Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Avanafil API Revenue Share by Country (2017-2028)
Figure 89. Turkey Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Avanafil API Revenue (2017-2028) & (US$ Million)
Figure 92. Avanafil API Value Chain
Figure 93. Avanafil API Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed